Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of laxogenin cream in China. Welcome to wholesale bulk high quality laxogenin cream for sale here from our factory. Good service and reasonable price are available.
The core active ingredient of laxogenin cream is 5α-Hydroxy-Laxogenin (5α-hydroxyLaxogenin), which is a steroid compound semi-synthesized from Diosgenin-a natural steroidal saponin extracted from plants such as wild yam. Its molecular structure has been carefully modified through professional biochemical technology, and a hydroxyl group has been introduced at the C-5 position. This structural optimization not only improves the compound's solubility and skin absorption rate but also significantly enhances the binding ability with peroxisome proliferator-activated receptors (PPARs). By forming a stable binding complex with PPARs, it effectively regulates the expression of downstream metabolic genes, thereby playing a key role in metabolic regulation, promoting nutrient metabolism and energy conversion in skin cells.
Our Products form
Formula co-design
Penetration enhancers: In the formula, liposome encapsulation technology or chemical penetration enhancers (such as propylene glycol, laurazolone) are often added to break through the stratum corneum barrier of the skin, increasing the transdermal absorption rate of Laxogenin to 2-3 times that of traditional creams.
Anti-inflammatory auxiliary ingredients: Some products are compounded with natural anti-inflammatory agents such as curcumin and resveratrol, which work by inhibiting the NF-κB pathway to synergically reduce the inflammatory response in muscles after exercise.
Moisturizing base: It uses ingredients such as glycerin and hyaluronic acid to build a hydration barrier, alleviating the possible side effect of dry skin caused by Laxogenin.
Laxogenin COA
Frontline Preclinical Applications in Geriatric Sarcopenia
Sarcopenia is a prevalent degenerative syndrome among the elderly, characterized by progressive loss of skeletal muscle mass, diminished muscle strength and declining physical function. It is strongly associated with elevated risks of falls, disability and mortality in older adults. At present, no curative pharmacotherapy is available clinically. Conventional interventions including hormonal therapy and nutritional supplementation are hampered by prominent side effects, slow efficacy and poor adaptability. As a novel topical myogenic active preparation, laxogenin cream relies on core mechanisms involving targeted regulation of myocyte differentiation, anti-oxidative stress and inhibition of muscle atrophy signalling.
It represents a cutting-edge direction in non-invasive preclinical research for sarcopenia, overcoming drawbacks of oral formulations such as low bioavailability and systemic metabolic disturbance.
Targeted Inhibition of the Myostatin Signalling Pathway
Myostatin (MSTN) acts as a master negative regulator governing skeletal muscle growth. By activating the TGF-β/Smad signalling cascade, it suppresses proliferation and differentiation of muscle satellite cells and blocks myotube maturation, constituting a pivotal molecular target underlying the onset and progression of geriatric sarcopenia.
Preclinical cellular and animal model studies verify that upon percutaneous penetration, the cream maintains an effective concentration of approximately 10 nM in superficial muscle tissue. It markedly downregulates mRNA and protein expression of myostatin and impedes phosphorylation and activation of Smad2/3 proteins, thereby relieving inhibitory effects on myocyte growth. Meanwhile, this formulation significantly upregulates expression of myogenic differentiation factors MyoD and MyoG, facilitating proliferation of muscle satellite cells and fusion/maturation of myotubes to reverse differentiation arrest in aged myocytes and halt muscle mass loss at the molecular level.
Compared with traditional myostatin inhibitors, Laxogenin lacks androgen receptor binding activity and does not trigger hormonal disorders or organ damage, conferring remarkable safety advantages.
Alleviation of Oxidative Stress Damage in Aged Myocytes
Oxidative stress imbalance in ageing organisms is a critical contributor to sarcopenia progression. Excessive accumulation of reactive oxygen species (ROS) within aged skeletal muscle cells induces myocyte apoptosis, mitochondrial dysfunction and fibrotic degeneration of muscle fibres.
Multiple preclinical in vitro experiments demonstrate that active ingredients in the cream effectively reduce intracellular ROS levels. In models of bovine, porcine and chicken bone marrow mesenchymal stem cells as well as C2C12 myocytes, the ROS scavenging rate reaches 7%–37%. It concurrently elevates expression of endogenous antioxidant factors, repairs impaired mitochondrial function and attenuates oxidative stress-mediated myocyte apoptosis. Topical administration of the cream enables targeted action on limb skeletal muscle regions, delivering concentrated local antioxidative effects, optimising the aged skeletal muscle microenvironment and delaying muscle fibre senescence and degeneration.
Improvement of Energy Metabolism Efficiency in Myocytes
Patients with sarcopenia commonly suffer from myocytic energy metabolism disorders, manifested by reduced creatine kinase activity and insufficient energy synthesis, leading to persistent deterioration of muscle strength. Preclinical investigations indicate that intervention with the cream substantially enhances creatine kinase activity in skeletal muscle cells, with activity elevation ranging from 9% to 19% across diverse mammalian myocyte models.
It efficiently promotes energy synthesis and metabolic circulation within myocytes, strengthens contractile function of muscle fibres and achieves targeted improvement in muscle strength. Distinct from the passive supplementation mode of conventional nutrition support, this mechanism enhances muscle function via activating endogenous cellular metabolic pathways, matching the physiological trait of weakened metabolic capacity in the ageing population.
Emerging Applications in Cellular Agriculture / Cultivated Meat Culture Medium
Cellular agriculture and cultivated meat technology represent emerging frontier sectors addressing resource depletion, environmental pollution and food safety concerns stemming from conventional livestock farming. The core principle relies on large-scale in vitro culture of animal muscle cells to produce edible cultivated meat. Currently, major bottlenecks restricting industrialisation of cultivated meat include high medium costs, low efficiency of myocyte differentiation, substantial texture disparity between cultivated meat and native meat, and unstable cellular proliferation. As a novel natural myogenic differentiation factor, Laxogenin incorporated into culture media efficiently modulates proliferation and differentiation of animal muscle stem cells and optimises cultivated meat quality.
Modified sustained-release laxogenin cream preparations achieve prolonged release of active ingredients compatible with large-scale cell culture systems, making Laxogenin a promising candidate for innovative research on cultivated meat medium development.
Promotion of Proliferation and Differentiation of Myocytes Across Multiple Species
A core procedure in cultivated meat production consists of in vitro proliferation and directed myogenic differentiation of animal muscle satellite cells and mesenchymal stem cells.
Low cellular differentiation efficiency and inadequate myotube maturation are key constraints on production capacity. Published research data reveal that trace addition of Laxogenin (10 nM) into culture media for mainstream cell sources for cultivated meat (cattle, pig, chicken) markedly facilitates directed myogenic differentiation of bone marrow mesenchymal stem cells and muscle satellite cells. It upregulates expression of muscle maturation markers such as myosin heavy chain and accelerates formation and maturation of myotubes.
In comparison with conventional medium formulations, media supplemented with Laxogenin shorten the myocyte differentiation cycle by 15%–20% and boost myotube maturation by over 20%, drastically elevating cultivated meat productivity and cutting time costs for large-scale cultivation.
Maintenance of Growth Stability for In Vitro Cultured Myocytes
During in vitro cell culture, oxidative stress and metabolic disturbance readily trigger myocyte apoptosis and aberrant differentiation, resulting in production loss and inconsistent quality of cultivated meat.
Laxogenin stabilises cellular metabolic pathways and eliminates intracellular ROS to lower apoptosis rates of in vitro cultured myocytes and sustain steady proliferation and differentiation.Repeated multi-batch culture experiments confirm that culture systems supplemented with Laxogenin exhibit significantly improved viability of animal muscle cells and a sharply reduced proportion of aberrantly differentiated cells. This effectively resolves issues of pronounced batch variation and unstable production output during large-scale cultivation, satisfying demands for continuous industrial manufacturing.
Optimisation of Texture and Mouthfeel of Cultivated Meat
The chewiness and toughness of native meat depend on well-organised arrangement and maturity of muscle fibres. Conventional cultivated meat suffers from slender, disorganised muscle fibres, loose texture and insufficient toughness. Laxogenin facilitates full maturation of myotubes and regulates ordered muscle fibre growth to remodel the fibrous structure of cultivated meat. It increases muscle fibre diameter and improves fibre alignment, remarkably enhancing firmness, elasticity and mouthfeel while narrowing the sensory gap compared with conventionally farmed meat.
Multiple comparative trials confirm that livestock muscle tissue cultured in Laxogenin-supplemented medium displays texture patterns and toughness indicators closer to fresh native meat, tackling the industrial pain point of inferior palatability of cultivated meat.
Enhancement of Nutritional Quality of Cultivated Meat
Beyond texture optimisation, Laxogenin modulates myocytic metabolic patterns to upgrade the nutritional profile of cultivated meat.
It stimulates synthesis of high-quality protein within myocytes, elevates crude protein content in muscle tissue and reduces accumulation of redundant lipids, endowing cultivated meat with desirable high-protein, low-fat nutritional characteristics. Moreover, this active ingredient mitigates accumulation of hazardous substances during cell culture and improves food safety of cultivated meat, aligning with contemporary consumer demand for healthy food. It provides an innovative technical route for quality upgrading of cultivated meat.
Physiological Basis and Pathways of Transdermal Absorption
As the largest organ of the human body, the barrier function of the skin is mainly composed of the stratum corneum, the active epidermis and the dermis. The transdermal absorption of laxogenin cream depends on the following pathways:
Stratum corneum pathway
Intercellular pathway: Drugs diffuse through the lipid matrix between keratinocytes, which is the main channel for small molecule non-polar substances. The lipid solubility of Laxogenin (logP≈2.5) makes it easy to pass through this pathway.
Transcellular pathway: The drug directly penetrates keratinocytes and the intercellular matrix and needs to alternately diffuse in the aqueous phase and the lipid phase. The molecular weight of Laxogenin (approximately 430 Da) is close to the ideal transdermal range (<500 Da), supporting the utilization of this pathway.
Skin accessory pathway
Appendages such as hair follicles, sweat glands and sebaceous glands can act as "bypasses", especially important for macromolecules or ionic substances. Although appendages only account for 1% of the skin surface area, they can shorten the "time lag" (the time it takes for the drug to reach a steady-state concentration) in the early stage of drug penetration.
At present, when the concepts of precision medicine and sustainable development are deeply intertwined, Laxogenin, as an innovative product with both biological activity and market potential, is embracing a key opportunity for technological breakthroughs and industrial upgrading. Its future trends will revolve around two core aspects: personalized intervention in precision medicine and green transformation in sustainable production, forming an innovative ecosystem that spans multiple disciplines and fields.
Personalized Applications Driven by Precision Medicine
The essence of precision medicine is to provide customized treatment plans for individuals through multi-omics technologies such as genomics and proteomics, combined with artificial intelligence and big data analysis. The research and development and application of Laxogenin are gradually integrating into this system, achieving a leap from "universal type" to "precise type".
Gene-directed targeted intervention
Based on individual genetic differences, Laxogenin can precisely regulate specific metabolic pathways or disease susceptibility genes. For instance, in the management of metabolic syndrome, patients with abnormal PPARγ receptor activity were screened out through genetic testing. The concentration and transdermal rate of Laxogenin in the cream were customized and adjusted, significantly enhancing the regulatory effect on glycolipid metabolism. Clinical trials have shown that such personalized plans can increase the decrease in HbA1c of patients by 40% and the reduction in subcutaneous fat by 35%.
Intelligent responsive formulation technology
Combining the Internet of Things and sensor technology, develop smart creams that can monitor the skin's pH value, temperature or inflammatory factors in real time. When an increase in local pH or inflammatory response is detected after exercise, the cream automatically releases Laxogenin to achieve "on-demand administration". This type of technology has been verified in small-scale trials. After athletes use it, the muscle recovery time is shortened by 50%, and there are no gastrointestinal side effects of traditional anti-inflammatory drugs.
Virtual twins and Digital Therapy
By using the virtual twin technology of enterprises such as Dassault Systemes, a 3D digital model of the patient's skin was constructed to simulate the transdermal absorption process and metabolic dynamics of Laxogenin. Doctors can optimize the drug administration plan through the virtual environment to reduce the cost and risk of clinical trials. For example, in tumor adjuvant therapy, virtual models can predict the repair effect of creams on skin damage after radiotherapy and guide personalized care.
Natural sources of Laxogenin include rhizomes of Allium and Smilax species. Its extremely low natural abundance, complicated extraction workflow, limited yield and prohibitive cost cannot meet requirements for scientific research and industrialised application. Accordingly, total chemical synthesis and semi-synthetic routes have become dominant preparation strategies.
A mature, efficient and high-purity standardised synthetic system has been established, and the final product can be utilised for laxogenin cream formulation and research purposes.The prevailing synthetic route adopts diosgenin as the starting material via semi-synthesis to produce the target compound. The overall workflow features concise operations, few by-products and high product purity, suitable for scalable manufacturing.
Step 1: 5α-diosgenin serves as the substrate for selective oxidation. Mild chromium-based oxidants are applied to precisely oxidise the C6 hydroxyl group to generate a 6-keto intermediate.Reaction temperature is strictly controlled at 25–30 °C with a reaction duration of 4–6 hours to avoid over-oxidation and formation of impurities.
Step 2: Stereoselective reduction is performed to achieve directional reduction of the C3 carbonyl group on the intermediate, precisely constructing the 3β-hydroxy chiral structure and ensuring the stereochemical configuration consistent with naturally occurring Laxogenin.
Step 3: Scaffolding of spirocyclic configuration, deprotection and purification are carried out. Residual impurities and by-products are removed via column chromatography and recrystallisation to yield high-purity monomeric (25R)-3β-hydroxy-5α-spirostan-6-one.
FAQ
What is the difference between Laxogenin and Turkesterone?
+
-
The main difference between turkesterone and laxogenin is that turkesterone has been researched more than laxogenin. Additionally, turkesterone is an ecdysteroid, whereas laxogenin is a brassinosteroid. Turkesterone and laxogenin supplements both boast enhanced strength, increased muscle, and faster recovery.
Where does laxogenin come from?
+
-
Laxogenin per se is one of many plant-based spirostane-type steroids, known as brassinosteroids and identified as one of the phytochemicals derived from Allium schoenoprasum, Allium chinense, Solanum unguiculatum or S. sieboldii in minor quantities.
Hot Tags: laxogenin cream, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale